IRSH: J.P. Morgan Securities plc.: Form 38.5 - Elan Corporation plc
IRSH: J.P. Morgan Securities plc.: Form 38.5 - Elan Corporation plc UK Regulatory Announcement LONDON FORM 38.5 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED) DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS 1. KEY INFORMATION Name of exempt market-maker J.P. Morgan Securities plc Company dealt in Elan Corporation plc Class of relevant security to which the Ordinary Shares dealings being disclosed relate (Note 1) Date of dealing 17 May 2013 2. DEALINGS (Note 2) Purchases and sales Total number of relevant secuities Highest price paid Lowest price paid acquired (Note 3) (Note 3) 24,200 8.8766 EUR 8.8766 EUR Total number of relevant Highest price received Lowest price received securities disposed (Note 3) (Note 3) 24,200 8.8766 EUR 8.8766 EUR (b) Derivatives transactions (other than options transactions) Product name Nature of transaction Number of relevant securities Price per unit e.g. CFD (Notes 5) (Notes 3) (Note 4) (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product Writing, Number of Type, name, selling, securities e.g. Option money e.g. purchasing, to which Exercise American, Expiry paid/received call varying the option price European date per unit options etc. relates etc. (Note 3) (Note5) (ii) Exercising Product name, Number of securities Exercise price per unit (Note 3) e.g. call options 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Date of disclosure 20 May 2013 Contact name Jay Supaya Telephone number +44 (0) 207 134 6126 Name of offeree/offeror with which Echo Pharma Acquisitions Limited connected [Royalty Pharma] Nature of connection (Note 6) Adviser to Echo Pharma Acquisitions Limited [Royalty Pharma] Contact: J.P. Morgan Securities plc.